Nuveen Asset Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,837
| Closed | -$377K | – | 3498 |
|
|
2021
Q1 | $377K | Buy |
2,837
+105
| +4% | +$14K | ﹤0.01% | 3138 |
|
|
2020
Q4 | $435K | Buy |
2,732
+37
| +1% | +$5.89K | ﹤0.01% | 3071 |
|
|
2020
Q3 | $283K | Sell |
2,695
-235
| -8% | -$24.7K | ﹤0.01% | 3102 |
|
|
2020
Q2 | $355K | Buy |
2,930
+3
| +0.1% | +$363 | ﹤0.01% | 3008 |
|
|
2020
Q1 | $230K | Buy |
2,927
+526
| +22% | +$41.3K | ﹤0.01% | 2966 |
|
|
2019
Q4 | $707K | Sell |
2,401
-560
| -19% | -$165K | ﹤0.01% | 2811 |
|
|
2019
Q3 | $535K | Buy |
2,961
+666
| +29% | +$120K | ﹤0.01% | 2927 |
|
|
2019
Q2 | $916K | Buy |
+2,295
| New | +$916K | ﹤0.01% | 2775 |
|